The fact not to ignore: Mean blood pressure is the main predictor of increased arterial stiffness in patients with systemic rheumatic diseases

Advances in Medical Sciences

Volumn 62, Issue 2, 2017, Pages 223-229

  Čypienė, Alma ^a,b   Dadonienė, Jolanta ^a,b   Miltinienė, Dalia ^a,b   Rinkūnienė, Egidija ^a,b   Rugienė, Rita ^a,b   Stropuvienė, Sigita ^a,b   Badarienė, Jolita ^a,b   Laucevičius, Aleksandras ^a,b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b State Research Institute Centre for Innovative Medicine   (Lithuania)

Author keywords

Atherosclerosis; Blood pressure; Systemic rheumatic diseases; Vascular stiffness

Indexed keywords

ARTERIAL STIFFNESS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAROTID ARTERY; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ARTHRITIS, RHEUMATOID; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAROTID ARTERIES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SCLERODERMA, SYSTEMIC; VASCULAR STIFFNESS;

EID: 85019077744     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2017.01.005     Document Type: Article

References (40)

1. [1] Steyers, C.M., Miller, F.J., Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci 15:7 (2014), 11324–11349.
2. [2] Gargiulo, P., Marsico, F., Parente, A., Paolillo, S., Cecere, M., Casaretti, L., et al. Ischemic heart disease in systemic inflammatory diseases. An appraisal. Int J Cardiol 170:3 (2014), 286–290.
3. [3] Soriano, A., Afeltra, A., Shoenfeld, Y., Is atherosclerosis accelerated in systemic sclerosis? Novel insights. Curr Opin Rheumatol 26:6 (2014), 653–657.
4. [4] Kahlenberg, J.M., Kaplan, M.J., Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. Annu Rev Med 64 (2013), 249–263.
5. [5] Nikpour, M., Gladman, D.D., Urowitz, M.B., Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?. Lupus 22:12 (2013), 1243–1250.
6. [6] Davignon, J., Ganz, P., Role of endothelial dysfunction in atherosclerosis. Circulation 109:23 Suppl 1 (2004), III27–32.
7. [7] Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37:5 (2001), 1236–1241.
8. [8] Roman, M.J., Devereux, R.B., Schwartz, J.E., Lockshin, M.D., Paget, S.A., Davis, A., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 46:1 (2005), 194–199.
9. [9] Murdaca, G., Colombo, B.M., Cagnati, P., Gulli, R., Spanò, F., Puppo, F., Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis 224:2 (2012), 309–317.
10. [10] Bergholm, R., Leirisalo-Repo, M., Vehkavaara, S., Mäkimattila, S., Taskinen, M.-R., Yki-Järvinen, H., Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 22:10 (2002), 1637–1641.
11. [11] Sandoo, A., Dimitroulas, T., Veldhuijzen van Zanten, J.J.C.S., Smith, J.P., Metsios, G.S., Nightingale, P., et al. Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis. Clin Exp Rheumatol 30:June (3) (2012), 388–396.
12. [12] Doria, A., Iaccarino, L., Ghirardello, A., Zampieri, S., Arienti, S., Sarzi-Puttini, P., et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119:8 (2006), 700–706.
13. [13] Hettema, M.E., Bootsma, H., Kallenberg, C.G.M., Macrovascular disease and atherosclerosis in SSc. Rheumatol Oxf Engl 47:5 (2008), 578–583.
14. [14] Nussinovitch, U., Shoenfeld, Y., Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev 10:5 (2011), 259–266.
15. [15] Cypiene, A., Laucevicius, A., Venalis, A., Ryliskyte, L., Dadoniene, J., Petrulioniene, Z., et al. Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab). Proc West Pharmacol Soc 50 (2007), 119–122.
16. [16] Chatterjee Adhikari, M., Guin, A., Chakraborty, S., Sinhamahapatra, P., Ghosh, A., Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 41:5 (2012), 669–675.
17. [17] Cypiene, A., Kovaite, M., Venalis, A., Dadoniene, J., Rugiene, R., Petrulioniene, Z., et al. Arterial wall dysfunction in systemic lupus erythematosus. Lupus 18:6 (2009), 522–529.
18. [18] Cypiene, A., Dadoniene, J., Rugiene, R., Ryliskyte, L., Kovaite, M., Petrulioniene, Z., et al. The influence of mean blood pressure on arterial stiffening and endothelial dysfunction in women with rheumatoid arthritis and systemic lupus erythematosus. Med-Lith 46:8 (2010), 522–530.
19. [19] Chin, C.W.-L., Tan, R.S., Thumboo, J., Endothelial function and arterial stiffness assessment as early surrogate markers of vascular risk in patients with systemic lupus erythematosus. Clin Exp Rheumatol 31:2 (2013), 295–301.
20. [20] Cypiene, A., Laucevicius, A., Venalis, A., Dadoniene, J., Ryliskyte, L., Petrulioniene, Z., et al. The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 27:12 (2008), 1517–1522.
21. [21] Psarras, A., Soulaidopoulos, S., Garyfallos, A., Kitas, G., Dimitroulas, T., A critical view on cardiovascular risk in systemic sclerosis. Rheumatol Int 12 (2016), 1–11.
22. [22] Kelly, R., Hayward, C., Avolio, A., O'Rourke, M., Noninvasive determination of age-related changes in the human arterial pulse. Circulation 80:6 (1989), 1652–1659.
23. [23] Celermajer, D.S., Sorensen, K.E., Gooch, V.M., Spiegelhalter, D.J., Miller, O.I., Sullivan, I.D., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:8828 (1992), 1111–1115.
24. [24] Choy, E., Ganeshalingam, K., Semb, A.G., Szekanecz, Z., Nurmohamed, M., Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatol Oxf Engl 53:12 (2014), 2143–2154.
25. [25] Aviña-Zubieta, J.A., Choi, H.K., Sadatsafavi, M., Etminan, M., Esdaile, J.M., Lacaille, D., Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:12 (2008), 1690–1697.
26. [26] Solomon, D.H., Karlson, E.W., Rimm, E.B., Cannuscio, C.C., Mandl, L.A., Manson, J.E., et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:9 (2003), 1303–1307.
27. [27] Klocke, R., Cockcroft, J.R., Taylor, G.J., Hall, I.R., Blake, D.R., Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 62:5 (2003), 414–418.
28. [28] Foster, W., Lip, G.Y.H., Raza, K., Carruthers, D., Blann, A.D., An observational study of endothelial function in early arthritis. Eur J Clin Invest 42:5 (2012), 510–516.
29. [29] Dimitroulas, T., Sandoo, A., Hodson, J., Smith, J.P., Kitas, G.D., In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort. Scand J Clin Lab Invest 76:4 (2016), 331–337.
30. [30] Sandoo, A., Veldhuijzen van Zanten, J.J.C.S., Metsios, G.S., Carroll, D., Kitas, G.D., Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatol Oxf Engl 50:11 (2011), 2125–2139.
31. [31] Panoulas, V.F., Metsios, G.S., Pace, A.V., John, H., Treharne, G.J., Banks, M.J., et al. Hypertension in rheumatoid arthritis. Rheumatology 47 (2008), 1286–1298.
32. [32] Panoulas, V.F., Toms, T., Metsios, G.S., Stavropoulos-Kalinoglou, A., Kosovitsas, A., Milionis, H.J., et al. Target organ damage in patients with rheumatoid arthritis: The role of blood pressure and heart rate. Atherosclerosis 209:1 (2010), 255–260.
33. [33] Dimitroulas, T., Sandoo, A., Hodson, J., Smith, J.P., Kitas, G.D., In vivo microvascular and macrovascular endothelial function is not associated with circulating dimethylarginines in patients with rheumatoid arthritis: a prospective analysis of the DRACCO cohort. Scand J Clin Lab Invest 76:4 (2016), 331–337.
34. [34] Schoenfeld, S.R., Kasturi, S., Costenbader, K.H., The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review. Semin Arthritis Rheum 43:1 (2013), 77–95.
35. [35] Brodszki, J., Bengtsson, C., Länne, T., Nived, O., Sturfelt, G., Marsál, K., Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus. Lupus 13:12 (2004), 917–923.
36. [36] Chu, S.-Y., Chen, Y.-J., Liu, C.-J., Tseng, W.-C., Lin, M.-W., Hwang, C.-Y., et al. Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med 126:11 (2013), 982–988.
37. [37] Nordin, A., Jensen-Urstad, K., Björnådal, L., Pettersson, S., Larsson, A., Svenungsson, E., Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study. Arthritis Res Ther, 15(4), 2013, R87.
38. [38] Tyndall, A.J., Bannert, B., Vonk, M., Airò, P., Cozzi, F., Carreira, P.E., et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:10 (2010), 1809–1815.
39. [39] Man, A., Zhu, Y., Zhang, Y., Dubreuil, M., Rho, Y.H., Peloquin, C., et al. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 72:7 (2012), 1188–1193.
40. [40] Ngian, G.-S., Sahhar, J., Proudman, S.M., Stevens, W., Wicks, I.P., Van Doornum, S., Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis 71:12 (2012), 1980–1983.